Redox Limited (RDX.AX)
AUD 4.03
(0.25%)
AUD 4.03
(0.25%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 115.88 Million | 134.74 Million | -48.97 Million | 32.24 Million | 8.25 Million | 41.42 Million |
| Net Income | 90.23 Million | 80.73 Million | 88.02 Million | 47.57 Million | 33.15 Million | 28.54 Million |
| Depreciation & Amortization | 8.41 Million | 7.79 Million | 7.23 Million | 6.73 Million | 6.74 Million | 1.79 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 18.33 Million | 32.79 Million | -141 Million | -20.56 Million | -35.7 Million | 13.05 Million |
| Other non-cash items | -8 Million | -7.46 Million | 162.09 Million | 37.99 Million | 53.36 Million | -10.24 Million |
| Investing Cash Flow | -125.25 Million | -2.8 Million | -1.21 Million | -2.09 Million | -2.13 Million | -1.73 Million |
| Investments in PPE | -3.82 Million | -3.11 Million | -1.58 Million | -2.36 Million | -2.13 Million | -1.91 Million |
| Acquisitions | -1.42 Million | 306 Thousand | 366 Thousand | 269 Thousand | - | 179.57 Thousand |
| Investment purchases | -120 Million | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 386 Thousand | 306 Thousand | 366 Thousand | 269 Thousand | - | 179.57 Thousand |
| Financing Cash Flow | 30.88 Million | -137.04 Million | 67.74 Million | -25.48 Million | -10.1 Million | -31.6 Million |
| Debt repayment | -167.12 Million | -49.73 Million | -109.92 Million | -12.51 Million | -3.93 Million | -31.6 Million |
| Dividends payments | -31.5 Million | -81.75 Million | -37.05 Million | -8.69 Million | - | - |
| Common Stock Repurchased | -5.37 Million | - | - | - | - | - |
| Common Stock Issuance | 235.62 Million | - | - | - | - | - |
| Other Financing Activities | -6.11 Million | -5.55 Million | -5.12 Million | -4.26 Million | -6.16 Million | -31.6 Million |
| Accounts receivables | 25.35 Million | -7.08 Million | -58.97 Million | -18.5 Million | -8.74 Million | -2.7 Million |
| Accounts payables | -2.57 Million | -14.8 Million | 41.73 Million | 6.72 Million | 14.67 Million | 6.2 Million |
| Inventory | 957 Thousand | 58.35 Million | -133.61 Million | -14.25 Million | -41.75 Million | 8.37 Million |
| Other working capital | -5.41 Million | -3.66 Million | 9.84 Million | 5.45 Million | 121.2 Thousand | 1.17 Million |
| Cash at beginning of period | 35.02 Million | 40.59 Million | 23.24 Million | 19.17 Million | 22.7 Million | 14.07 Million |
| Cash at end of period | 56.66 Million | 35.02 Million | 40.59 Million | 23.24 Million | 19.17 Million | 22.7 Million |
| Capital Expenditure | -3.82 Million | -3.11 Million | -1.58 Million | -2.36 Million | -2.13 Million | -1.91 Million |
| Effect of forex changes on cash | 124 Thousand | -461 Thousand | -198 Thousand | -599 Thousand | 464.9 Thousand | 545.58 Thousand |
| Net cash flow / Change in cash | 21.63 Million | -5.56 Million | 17.35 Million | 4.07 Million | -3.53 Million | 8.62 Million |
| Free Cash Flow | 112.06 Million | 131.63 Million | -50.56 Million | 29.88 Million | 6.11 Million | 39.51 Million |
| Breakdown | 2023 FY | 2023 Q4 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 90.23 Million | 50.66 Million | 39.56 Million | 19.78 Million | 43.68 Million | 80.73 Million |
| Depreciation & Amortization | 8.41 Million | 4.27 Million | 4.13 Million | 2.07 Million | 3.92 Million | 7.79 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 18.33 Million | - | - | - | 25.39 Million | 32.79 Million |
| Other non-cash items | -8 Million | -10.75 Million | 44.82 Million | 18.27 Million | 58.21 Million | -7.46 Million |
| Investing Cash Flow | -125.25 Million | -41.45 Million | -83.8 Million | -41.9 Million | -966 Thousand | -2.8 Million |
| Investments in PPE | -3.82 Million | -1.64 Million | -2.17 Million | -1.08 Million | -1.25 Million | -3.11 Million |
| Acquisitions | -1.42 Million | 197 Thousand | -1.62 Million | -907.5 Thousand | 290 Thousand | 306 Thousand |
| Investment purchases | -120 Million | -40 Million | -80 Million | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | -39.9 Million | -39.9 Million | 145 Thousand | 306 Thousand |
| Financing Cash Flow | 30.88 Million | -32.55 Million | 63.43 Million | 31.71 Million | -87.51 Million | -137.04 Million |
| Debt repayment | -167.12 Million | -2.04 Million | -169.16 Million | - | -35.17 Million | -49.73 Million |
| Dividends payments | -31.5 Million | -31.5 Million | - | - | -49.54 Million | -81.75 Million |
| Common Stock Repurchased | -5.37 Million | - | - | - | - | - |
| Common Stock Issuance | 235.62 Million | - | 235.62 Million | - | - | - |
| Other Financing Activities | -6.11 Million | -3.08 Million | 31.71 Million | 31.71 Million | -18.98 Million | -5.55 Million |
| Accounts receivables | 25.35 Million | - | - | - | -3.54 Million | -7.08 Million |
| Accounts payables | -2.57 Million | - | - | - | - | -14.8 Million |
| Inventory | 957 Thousand | - | - | - | 29.17 Million | 58.35 Million |
| Other working capital | -5.41 Million | - | - | - | -236 Thousand | -3.66 Million |
| Cash at beginning of period | 35.02 Million | 94.92 Million | 35.02 Million | - | 25.78 Million | 40.59 Million |
| Cash at end of period | 56.66 Million | 56.66 Million | 94.92 Million | 29.94 Million | 35.02 Million | 35.02 Million |
| Capital Expenditure | -3.82 Million | -1.64 Million | -2.17 Million | -1.08 Million | -1.25 Million | -3.11 Million |
| Effect of forex changes on cash | 124 Thousand | - | 5500.00 | 5500.00 | -125 Thousand | -461 Thousand |
| Net cash flow / Change in cash | 21.63 Million | -38.25 Million | 59.89 Million | 29.94 Million | 9.24 Million | -5.56 Million |
| Free Cash Flow | 112.06 Million | 33.98 Million | 78.07 Million | 39.03 Million | 96.72 Million | 131.63 Million |
HARIOMPIPE
CMMB
AW1
7112
CLN
ALFUW